MAIOLI, SARA
MAIOLI, SARA
Dipartimento di Scienze Cliniche e di Comunità
Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab
2024 I. Muller, S. Maioli, M. Armenti, L. Porcaro, N. Currò, E. Iofrida, L. Pignataro, J. Manso, C. Mian, J. Geginat, M. Salvi
Long-term outcome of thyroid abnormalities in patients with severe Covid-19
2023 I. Muller, A. Daturi, M. Varallo, T.E. Re, D. Dazzi, S. Maioli, E. Crivicich, F. Di Marco, V. Longari, B. Dazzi, M. Castellani, G. Mantovani, M. Arosio, M. Salvi
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype
2023 Y. Silvestri, F. Clemente, G. Moschetti, S. Maioli, E. Carelli, A. Espadas de Arias, R. Torelli, E. Longhi, T. De Feo, M. Crosti, M.L. Sarnicola, M. Salvi, G. Mantovani, M. Arosio, M. Bombaci, E. Pesce, R. Grifantini, S. Abrignani, J. Geginat, I. Muller